lifestyle.entreprenerd.net

Author: CorMedix, Inc.

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

April 27, 2026
CorMedix to Participate in Needham Virtual Healthcare Conference

April 7, 2026